CorTec GmbH was again included in this year's list of the most innovative companies in Germany. It had already been honored in 2018.
Rumors have it that BioNTech is preparing for an IPO on the US technology exchange Nasdaq. According to Reuters, the company has entrusted two US banks with the preparations.
For his work on cancer immunotherapies, Professor Ugur Sahin, founder and CEO of BioNTech AG, was honored with this year's German Cancer Award.
The EU consortium led by iThera Medical is funded by the European Fast Track to Innovation programme. The aim is to advance the so-called MSOT technology.
Since 2015, BioNTech AG and Sanofi have been partners in the development of cancer therapies. The cooperation is now being extended with an investment of 80 million euros.